Projects and collaborations

Projects and collaborations

Grants from the Research Council of Lithuania:

MIP-039/2015 "development of new diagnostic tools for hepatitis E virus (HEV) and studies on HEV prevalence in Lithuania" (2015-2018). Coordinator - I. Kučinskaitė-Kodzė.

S-MIP-17-49 „The prevalence and distribution of virulence factors among subgroups of vaginal bacteria Gardnerella vaginalis“ (2017-2020). Coordinator - M. Plečkaitytė.

Project No. 01.2.2-LMT-K-718-01-0008 „New technologies for development of recombinant allergens“ under the Measure No. 01.2.2-LMT-K-718, 2017-2020. Coordinator – G.Žvirblis (VU), participants: M.Simanavičius, K.Juškaitė, M.Plečkaitytė, V.Rudokas, A. Žvirblienė.

National research program “Healthy ageing”, project SEN-14/2015 „Investigation of Genetic and Epigenetic Prognostic Markers for Prediction of Clinical Course of Papillary Thyroid Cancer (PTC) in Different age Groups”, 2015-2018. Coordinator - B.Žilaitienė (LSMU), participants: A. Žvirblienė, D. Stravinskienė, E.Leiputė.

Post-doctoral fellowship No. 09.3.3-LMT-K-712-02-0094 „Investigation of pneumolysin by immunoassays“ (2017-2019), I. Kučinskaitė-Kodzė.

Post-doctoral fellowship No. 09.3.3-LMT-K-712-02-0095 „Alternative pre-iRNR splicing: association between hypoxia and neurodegenerative disorders“ (2017-2019), E. Jakubauskienė.

• Contracts with industrial partners:

• UAB Imunodiagnostika No. 52-1705/TPS-600000-974, 2017-2019
• UAB Imunodiagnostika No. 51-1705/TPS-600000-966, 2017-2019
• Kalon Biological Ltd. (UK)
• Abcam Ltd. (UK)
• Santa Cruz Biotechnology (USA)
• ArcDia (Finland)

Collaboration partners

• Karolinska Institute (Sweden)
• Oslo University (Norway)
• Friedrich-Loeffler Institute, Institute for Novel and Emerging Infectious Diseases (Germany)
• Justus-Liebig University Giessen (Germany)
• ArcDia (Finland)